Tag: CORONA Remedies financial performance

CORONA Remedies: Q1FY26 vs Q2FY26 performance comparison

DBT Bureau Pune, 2 Jan 2026 CORONA Remedies reported a steady improvement in quarterly performance during Q2FY26, driven by higher revenues and improved profitability margins compared to the previous quarter. ...

News

Hindustan Unilever Limited reshapes portfolio with OZiva acquisition, Nutritionalab stake sale

DBT Bureau Pune, 13 Feb 2026 Hindustan Unilever Limited reported two strategic moves in its Health & Wellbeing business -...

Artificial Intelligence

Wesfarmers teams up with Google cloud to supercharge retail with agentic AI

DBT Bureau Pune, 13 Feb 2026 Wesfarmers, an Australian conglomerate with businesses ranging from retail and health to chemicals, energy,...

Commodity

Strong U.S. jobs data pressures gold, oil holds firm on supply risks

DBT Bureau Pune, 13 Feb 2026 Geojit Investments’ latest report highlights softer precious metals, resilient crude oil prices amid geopolitical...

Data Story

ONGC delivers robust Q3 FY26: Higher profit, strong dividend, stable output

DBT Bureau Pune, 13 Feb 2026 Highlights: Posts consolidated net profit of ₹ 11,946 crore during Q3 FY’26, up by...

Hindustan Unilever Limited reshapes portfolio with OZiva acquisition, Nutritionalab stake sale

Wesfarmers teams up with Google cloud to supercharge retail with agentic AI

Strong U.S. jobs data pressures gold, oil holds firm on supply risks

ONGC delivers robust Q3 FY26: Higher profit, strong dividend, stable output

HAL trades in green on strong Q3FY26 performance & Dornier deal

M&M posts strong Q3FY26 results: SUV share improves

Airtel’s new AI solution targets rising OTP-related financial fraud

Why IT stocks are falling?

BHEL OFS opens for retail investors from tomorrow

Britannia stock ended 2.6% up post inline Q3FY26 results

CAI retains India cotton output estimate for 2025-26: Kedia Advisory

Oil India Q3FY26 PAT steady at ₹1,436 crore; Board declares ₹7 interim dividend

Tag: CORONA Remedies financial performance

CORONA Remedies: Q1FY26 vs Q2FY26 performance comparison

Hindustan Unilever Limited reshapes portfolio with OZiva acquisition, Nutritionalab stake sale

Wesfarmers teams up with Google cloud to supercharge retail with agentic AI

Strong U.S. jobs data pressures gold, oil holds firm on supply risks

ONGC delivers robust Q3 FY26: Higher profit, strong dividend, stable output

Navigate Site

Welcome Back!

Retrieve your password

Add New Playlist

Are you sure want to unlock this post?

Are you sure want to cancel subscription?

Tag: CORONA Remedies financial performance

Navigate Site

Follow Us

Welcome Back!

Retrieve your password

Add New Playlist

Are you sure want to unlock this post?

Are you sure want to cancel subscription?